Longitudinal Safety Outcomes of Anti-tumor Necrosis Factor Alpha Therapy in the Treatment of Inflammatory Bowel Disease
Related Posts
Ma L, Wu C, Wang L, Lee HL, Chen J, Hu Z, Xie Y, Pandol SJ, Gaddam S, Li D, Christodoulou AG. Non-Rigid Motion-Compensated MR[...]
Chang L, Corsetti M, Chey WD, Ford AC, Schmulson MJ, Shin A, Barbara G, Ballou S, Mayer EA, Siah KT, Simrén M, Staudacher H, Lembo[...]
Rex DK, Anderson JC, Burke CA, Jacobson BC, May FP, Patel SG, Samadder NJ, Stoffel EM, Robertson DJ. Serrated Polyposis Syndrome: A Review and Consensus[...]